MOL CANCER 润色咨询

Molecular Cancer

出版年份:2002 年文章数:175 投稿命中率:39.13%

出版周期:Irregular 自引率:2.0% 审稿周期:平均3.54月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均3.54月 (网友贡献,非官方数据)
投稿命中率
39.13% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
4290.0元/篇 (网友贡献,非官方数据)
中国人发表比例
2019年中国人文章占该期刊总数量85.14% (2018年为54.24%)
自引率
2.0 %
年文章数
175
期刊官网
点击查看 (点击次数:22833)
点击查看 (点击次数:8442次)
作者需知
点击查看 (点击次数:819次)
期刊简介
稿件收录要求

Published by BioMed Central. ISSN: 1476-4598.

Molecular Cancer is an Open Access, peer-reviewed online journal interested in original research and commentary in all areas of cancer and related biomedical science. Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Molecular Cancer will consider articles from any area of cancer-related biomedical research, including, but not limited to: angiogenesis; animal models; metastasis; cancer antigens and the immune response to them; cellular signalling and molecular biology; epidemiology; genetic and molecular profiling of cancer; prevention, diagnosis and therapy of cancer; and vaccine- and antibody-based cancer therapies. Molecular Cancer, a forum for exciting findings in the field of cancer-related research, is an Open Access journal, providing an unparalleled opportunity to present information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information.

打开APP